search for




 

Economic Evaluation of Introducing Public Health Pharmacist
Yakhak Hoeji 2019;63(5):282-291
Published online October 31, 2019
© 2019 The Pharmaceutical Society of Korea.

Jaewon Kim*, Seung-Mi Choi**, and Dae-Won Kim***,#

*Institute of Health and Environment, Seoul National University
**Gachon University, General Graduate School
***Ajou University, General Graduate School
Correspondence to: Kim Dae-Won, Ajou University, General Graduate School, 206 worldcup-ro, Youngtong-gu, Suwon-si, Gyeonggi-do 16499, Republic of Korea
Tel: +82-31-239-1832, Fax: +82-31-239-1833 E-mail: kdw374@hanmail.net
Received June 19, 2019; Revised October 2, 2019; Accepted October 8, 2019.
Abstract
This study was to evaluate economic impact of the Public Health Pharmacist, in a societal perspective. We set the work scope of Public Health Pharmacist as supporting of filling a prescription in public hospitals, medication counseling and night time pharmacist in health center. Clinical outcomes of Public Health Pharmacist included drug compliance increase, social hospitalization reduction, and late night pharmaceutical accessibility improvement. And as result of drug compliance increase, inappropriate medication discontinuation, subsequent drug-related morbidity and mortality reduction might take place. Economic outcomes included cost savings from direct medical cost reduction such as medication and healthcare utilization and indirect cost of family members and care-givers. Input costs for Public Health Pharmacist included payroll costs, indirect expenses for the personnel, health center operating expenses for night time, medical material expenses, and telephone and visiting expenses for medication counseling service. Model parameters for outcomes were derived from published literatures, and costs were from literatures and health insurance statistical data in Korea. Annual costs and benefits were estimated in the year of 2018. We assumed that 1,347 public health pharmacist would be in charge, and their service meet the need of over 65 population fully, and that of the whole population in Korea in case of the “public night pharmacy.” Cost for Public Health Pharmacist was ₩70,974,390,845 per year and benefit for Public Health Pharmacist was ₩180,167,236,698 per year. Benefit-to-cost ratio was 2.538:1 and net benefit was ₩109,192,845,853 per year. However, in a certain condition in sensitivity test, it was showed that benefit of Public Health Pharmacist may reduced considerably. This implied that the cost effectiveness and economic validity of Public Health Pharmacist depend on change of medical care utilization behaviors people. In conclusion, the economic validity of Public Health Pharmacist was at least neutral under several alternative scenarios.
Keywords : Economic evaluation, public health, pharmacist, drug compliance, night-time public pharmacy


October 2019, 63 (5)
Full Text(PDF) Free
Supplementary File

Social Network Service
Services

Cited By Articles
  • CrossRef (0)